FILTER
FILTERED INTERVIEW RESULTS
Tim Tyson
CHAIRMAN AND CEO, TRIRX PHARMACEUTICALS
"Great innovations and new medicines are emerging in the animal health space, especially in terms of biologics and monoclonal antibodies, and we saw great opportunities in this developing area."
Mike Radomsky
CEO, CMC PHARMACEUTICALS
"As biotech companies secure funding and advance their drug development programs, the demand for our services is expected to increase."
Mark Compton
EXECUTIVE DIRECTOR, AMERICAN EXPLORATION & MINING ASSOCIATION (AEMA)
"Relying solely on allies for our needs is no longer a viable strategy. While complete mineral independence may be challenging, responsibly utilizing our domestic resources whenever feasible is imperative."
Peter Richardson
EXECUTIVE MANAGING DIRECTOR, NEVADA GOLD MINES (NGM)
"We have tested autonomous trucks and underground battery-driven equipment, and currently we have several open-pit drills at Carlin operating autonomously."
Trevor Caswell
CHAIRMAN, PHARMA.AERO
"We now offer an open platform for life sciences companies to have conversations around priorities in their field and discuss challenges in the supply chain."
Ron White
DIRECTOR - SALES AND MARKETING, 3D-P
"Our commitment to being OEM and technology agnostic sets us apart, enabling collaboration with diverse technologies."
Travis Deti
EXECUTIVE DIRECTOR, WYOMING MINING ASSOCIATION (WMA)
"Wyoming is strategically positioned to address the geopolitical challenges affecting critical minerals, particularly in the uranium sector."
Greg Smith
PRESIDENT AND CEO, EQUINOX GOLD
"When operating at capacity, Greenstone will be our largest and lowest-cost mine, so we are really at a pivotal point in the company’s history."
Anwar Daud
MANAGING DIRECTOR, ZIM LABORATORIES
"We progressed on the development of our New Innovative Products (NIP), which are complex generics developed using in-house proprietary technology platforms."
Daniel Prince
CEO, PRINCE STERILIZATION SERVICES
"We are extremely excited about the growth our hydrogen peroxide and packaging segments can bring."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
